US Stock MarketDetailed Quotes

Akebia Therapeutics (AKBA)

Watchlist
  • 1.150
  • -0.010-0.86%
Close May 11 16:00 ET
  • 1.150
  • 0.0000.00%
Pre 05:45 ET
308.50MMarket Cap-14.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics (AKBA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-6.61%53.54M
47.46%236.2M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
Operating revenue
-6.61%53.54M
47.46%236.2M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
Cost of revenue
61.18%12.29M
-37.54%39.46M
-38.45%12.54M
-33.74%9.38M
-41.81%9.92M
-34.30%7.63M
-14.80%63.18M
9.11%20.37M
-21.37%14.16M
-1.37%17.05M
Gross profit
-17.01%41.25M
102.81%196.73M
72.54%45.09M
112.24%49.38M
97.56%52.55M
136.70%49.71M
-19.48%97M
-30.37%26.13M
-3.20%23.27M
-31.95%26.6M
Operating expense
26.94%45.95M
17.51%173.24M
32.64%53.64M
25.61%44.93M
8.88%38.46M
0.88%36.2M
-11.49%147.42M
11.84%40.44M
-3.07%35.77M
-26.68%35.33M
Selling and administrative expenses
18.23%30.44M
0.88%107.48M
-5.73%26.09M
9.72%29.09M
-1.34%26.56M
1.20%25.74M
6.30%106.55M
8.80%27.68M
16.76%26.52M
-0.44%26.92M
Research and development costs
51.80%14.81M
65.62%62.36M
126.10%26.65M
76.08%14.94M
44.02%11.01M
0.24%9.75M
-40.31%37.65M
19.47%11.79M
-36.33%8.49M
-62.14%7.65M
Other operating expenses
0.86%707K
5.47%3.4M
-7.67%903K
16.51%896K
17.59%896K
-1.41%701K
-0.53%3.22M
14.25%978K
-11.00%769K
-19.70%762K
Operating profit
-134.75%-4.7M
146.61%23.5M
40.22%-8.55M
135.58%4.45M
261.48%14.09M
190.83%13.51M
-9.42%-50.41M
-1,141.27%-14.31M
2.81%-12.51M
4.02%-8.73M
Net non-operating interest income expense
39.63%-4.69M
-32.96%-24.18M
29.81%-4.83M
28.72%-4.75M
-218.01%-6.83M
-211.05%-7.77M
-201.48%-18.19M
-384.98%-6.88M
-372.41%-6.66M
-30.88%-2.15M
Non-operating interest expense
-39.63%4.69M
32.96%24.18M
-29.81%4.83M
-28.72%4.75M
218.01%6.83M
211.05%7.77M
201.48%18.19M
384.98%6.88M
372.41%6.66M
30.88%2.15M
Other net income (expense)
24.73%459K
-274.97%-3.04M
232.41%2.15M
266.55%1.45M
-405.76%-7.01M
160.43%368K
-545.60%-811K
-346.20%-1.62M
-311.79%-873K
620.91%2.29M
Gain on sale of security
194.19%456K
-839.09%-3.1M
235.04%2.26M
271.03%1.46M
-399.44%-6.98M
220.16%155K
---330K
---1.68M
---856K
--2.33M
Special income (charges)
----
--0
--0
--0
--0
--0
18.44%-575K
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
--0
-67.96%58K
--0
--0
--0
-Less:Other special charges
----
----
----
----
----
----
-1.34%517K
--0
----
----
Other non- operating income (expenses)
-98.59%3K
-38.30%58K
-312.73%-117K
41.18%-10K
28.21%-28K
124.21%213K
-89.40%94K
-91.64%55K
60.47%-17K
-290.00%-39K
Income before tax
-246.07%-8.93M
94.64%-3.72M
50.73%-11.24M
105.76%1.16M
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
Income tax
126K
1.62M
1.01M
615K
0
0
0
0
Net income
-248.13%-9.05M
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
Net income continuous Operations
-248.13%-9.05M
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
Minority interest income
Net income attributable to the parent company
-248.13%-9.05M
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-248.13%-9.05M
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
Basic earnings per share
-200.00%-0.03
93.94%-0.02
50.00%-0.05
0
0
133.33%0.03
-17.86%-0.33
-3,197.89%-0.1
-25.00%-0.1
33.33%-0.04
Diluted earnings per share
-200.00%-0.03
93.94%-0.02
50.00%-0.05
0
0
133.33%0.03
-17.86%-0.33
-3,207.52%-0.1
-25.00%-0.1
33.33%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -6.61%53.54M47.46%236.2M23.93%57.62M57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M
Operating revenue -6.61%53.54M47.46%236.2M23.93%57.62M57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M
Cost of revenue 61.18%12.29M-37.54%39.46M-38.45%12.54M-33.74%9.38M-41.81%9.92M-34.30%7.63M-14.80%63.18M9.11%20.37M-21.37%14.16M-1.37%17.05M
Gross profit -17.01%41.25M102.81%196.73M72.54%45.09M112.24%49.38M97.56%52.55M136.70%49.71M-19.48%97M-30.37%26.13M-3.20%23.27M-31.95%26.6M
Operating expense 26.94%45.95M17.51%173.24M32.64%53.64M25.61%44.93M8.88%38.46M0.88%36.2M-11.49%147.42M11.84%40.44M-3.07%35.77M-26.68%35.33M
Selling and administrative expenses 18.23%30.44M0.88%107.48M-5.73%26.09M9.72%29.09M-1.34%26.56M1.20%25.74M6.30%106.55M8.80%27.68M16.76%26.52M-0.44%26.92M
Research and development costs 51.80%14.81M65.62%62.36M126.10%26.65M76.08%14.94M44.02%11.01M0.24%9.75M-40.31%37.65M19.47%11.79M-36.33%8.49M-62.14%7.65M
Other operating expenses 0.86%707K5.47%3.4M-7.67%903K16.51%896K17.59%896K-1.41%701K-0.53%3.22M14.25%978K-11.00%769K-19.70%762K
Operating profit -134.75%-4.7M146.61%23.5M40.22%-8.55M135.58%4.45M261.48%14.09M190.83%13.51M-9.42%-50.41M-1,141.27%-14.31M2.81%-12.51M4.02%-8.73M
Net non-operating interest income expense 39.63%-4.69M-32.96%-24.18M29.81%-4.83M28.72%-4.75M-218.01%-6.83M-211.05%-7.77M-201.48%-18.19M-384.98%-6.88M-372.41%-6.66M-30.88%-2.15M
Non-operating interest expense -39.63%4.69M32.96%24.18M-29.81%4.83M-28.72%4.75M218.01%6.83M211.05%7.77M201.48%18.19M384.98%6.88M372.41%6.66M30.88%2.15M
Other net income (expense) 24.73%459K-274.97%-3.04M232.41%2.15M266.55%1.45M-405.76%-7.01M160.43%368K-545.60%-811K-346.20%-1.62M-311.79%-873K620.91%2.29M
Gain on sale of security 194.19%456K-839.09%-3.1M235.04%2.26M271.03%1.46M-399.44%-6.98M220.16%155K---330K---1.68M---856K--2.33M
Special income (charges) ------0--0--0--0--018.44%-575K--0--0--0
-Less：Restructuring and merger&acquisition ------0--0--0--0--0-67.96%58K--0--0--0
-Less:Other special charges -------------------------1.34%517K--0--------
Other non- operating income (expenses) -98.59%3K-38.30%58K-312.73%-117K41.18%-10K28.21%-28K124.21%213K-89.40%94K-91.64%55K60.47%-17K-290.00%-39K
Income before tax -246.07%-8.93M94.64%-3.72M50.73%-11.24M105.76%1.16M102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M
Income tax 126K1.62M1.01M615K0000
Net income -248.13%-9.05M92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M
Net income continuous Operations -248.13%-9.05M92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M
Minority interest income
Net income attributable to the parent company -248.13%-9.05M92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -248.13%-9.05M92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M
Basic earnings per share -200.00%-0.0393.94%-0.0250.00%-0.0500133.33%0.03-17.86%-0.33-3,197.89%-0.1-25.00%-0.133.33%-0.04
Diluted earnings per share -200.00%-0.0393.94%-0.0250.00%-0.0500133.33%0.03-17.86%-0.33-3,207.52%-0.1-25.00%-0.133.33%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.43%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +12.13%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.78%
5
United States Oil Fund LP
USO
+7.93%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.11%
Sample Name
Sample Code
 +14.36%
Sample Name
Sample Code
 +9.91%
4
ASE Technology
ASX
+9.36%
5
Kingsoft Cloud
KC
+7.50%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -